Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BIIB | Biogen Inc. | 0.67% | 345.22 | 1.2% | $624.02m | |
| GILD | Gilead Sciences, Inc. | -3.53% | 72.92 | 0.9% | $510.71m | |
| CELG | Celgene Corporation | 0.24% | 90.37 | 1.2% | $496.41m | |
| AMGN | Amgen Inc. | 0.50% | 197.42 | 1.2% | $485.34m | |
| ILMN | Illumina, Inc. | -0.34% | 325.88 | 3.5% | $373.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.67% | 374.26 | 2.6% | $315.78m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.64% | 176.08 | 1.9% | $209.08m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.09% | 116.00 | 2.0% | $186.59m | |
| A | Agilent Technologies, Inc. | -1.28% | 64.66 | 1.5% | $159.27m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.52% | 130.25 | 16.6% | $142.46m | |
| NKTR | Nektar Therapeutics | 0.13% | 60.03 | 5.6% | $126.29m | |
| BLUE | Bluebird Bio, Inc. | 1.15% | 158.00 | 14.6% | $121.57m | |
| EXAS | Exact Sciences Corporation | 0.33% | 48.84 | 25.3% | $118.82m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.69% | 101.01 | 4.4% | $118.74m | |
| INCY | Incyte Corporation | 1.40% | 68.80 | 2.5% | $111.73m |
Company Profile
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of novel oligonucleotide therapeutics for oncology and rare diseases. The firm uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.